Wolverine BPC-157 10mg combines high-purity BPC-157 and TB-500 fragments into a 99% HPLC-verified lyophilized powder, engineered exclusively for in vitro tissue signaling and cell migration research.
Original price was: $ 250.$ 205Current price is: $ 205.
Wolverine BPC-157 10MG is a combined research formulation supplied as lyophilized powder for controlled in vitro laboratory research. The formulation contains BPC-157 and a TB-500-related peptide fragment according to the applicable product and batch documentation.
Each applicable batch undergoes analytical verification using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Batch-specific Certificate of Analysis (CoA) documentation provides information about product identity, analytical findings, and applicable quality characteristics.
Wolverine BPC-157 10MG is a molecular research material intended for laboratory investigations involving cellular and tissue signaling models. It is supplied exclusively for Research Use Only (RUO) and is intended for qualified research laboratories conducting controlled in vitro studies.
The formulation provides a defined multi-component research material for laboratory workflows. Research applications should be determined by qualified laboratory personnel according to validated laboratory methods and institutional procedures.
Wolverine BPC-157 10MG is intended for controlled in vitro research involving cellular signaling, tissue-model investigations, cell migration models, fibroblast-related laboratory models, and related biochemical research workflows.
Research applications should be selected by qualified laboratory personnel according to the objectives, equipment, and validated procedures of the research facility.
The product is supplied exclusively for scientific and laboratory research and should be evaluated according to the research requirements of the applicable laboratory.
Wolverine BPC-157 10MG should be handled according to applicable product documentation, validated laboratory procedures, and the Standard Operating Procedures (SOPs) of the research facility.
Follow the laboratory’s established procedures when preparing research materials for an applicable experimental workflow.
Store the unopened lyophilized material according to the storage conditions stated on the applicable product documentation or batch-specific Certificate of Analysis. Where the documented storage condition is -20°C, maintain the sealed product at that temperature and protect it from unsuitable environmental conditions.
Wolverine BPC-157 10MG is subject to analytical quality controls intended to support product identification and batch consistency.
Depending on the applicable batch documentation, analytical testing may include:
Analytical findings are documented in the applicable batch-specific Certificate of Analysis.
Every applicable production batch of Wolverine BPC-157 10MG undergoes quality review before release. Batch documentation may identify the product, batch or lot number, analytical findings, purity results, and other applicable quality information.
A Certificate of Analysis provides documented information associated with the tested batch and helps research facilities maintain appropriate laboratory records.
Additional technical or batch-specific documentation may be available through the BioPeak USA Technical Operations team upon request.
Wolverine BPC-157 10MG is supplied strictly for laboratory and scientific research and is classified as Research Use Only (RUO).
It is not intended for human or veterinary use and is not supplied for clinical or therapeutic applications. Handling should be limited to qualified laboratory personnel working according to applicable institutional policies, laboratory procedures, and regulatory requirements.
Customers are responsible for determining whether their intended research activities comply with applicable requirements and institutional policies.
Wolverine BPC-157 10MG is a lyophilized research formulation containing BPC-157 and a TB-500-related peptide fragment, supplied for controlled in vitro laboratory research.
The 10MG designation identifies the total quantity of material supplied in the applicable vial.
Wolverine BPC-157 10MG may be evaluated using HPLC and Mass Spectrometry according to the applicable batch testing documentation. Where supported by the batch documentation, purity is reported at ≥99%.
Yes. A batch-specific Certificate of Analysis is provided where applicable and documents analytical information associated with the tested batch.
Laboratory personnel should follow the applicable product documentation, validated laboratory procedures, and their facility’s Standard Operating Procedures (SOPs).
Follow the storage requirements stated in the applicable product documentation or Certificate of Analysis. Where the documented storage condition is -20°C, maintain the unopened lyophilized material at -20°C.
Wolverine BPC-157 10MG is intended exclusively for controlled laboratory and in vitro research involving applicable biochemical, cellular, and molecular research models.
Wolverine BPC-157 10MG provides qualified research facilities with a documented multi-component formulation for controlled laboratory investigations. Its lyophilized format, analytical verification, and batch-specific documentation provide research laboratories with relevant product and quality information.
BioPeak USA maintains a research-focused approach to product documentation, analytical testing, and batch-level quality records. For technical questions or batch documentation requests, contact the BioPeak USA Technical Operations team through the official website.
